Provided by Tiger Fintech (Singapore) Pte. Ltd.

LivaNova PLC

54.28
-0.6100-1.11%
Post-market: 54.280.00000.00%16:10 EDT
Volume:538.10K
Turnover:29.39M
Market Cap:2.96B
PE:-13.96
High:55.20
Open:54.87
Low:54.21
Close:54.89
52wk High:58.91
52wk Low:32.48
Shares:54.60M
Float Shares:54.41M
Volume Ratio:1.30
T/O Rate:0.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8890
EPS(LYR):1.17
ROE:-17.87%
ROA:5.12%
PB:2.64
PE(LYR):46.56

Loading ...

Company Profile

Company Name:
LivaNova PLC
Exchange:
NASDAQ
Establishment Date:
2015
Employees:
2900
Office Location:
20 Eastbourne Terrace,London,Greater London,United Kingdom
Zip Code:
W2 6LG
Fax:
- -
Introduction:
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Directors

Name
Position
Vladimir Makatsaria
Director and Chief Executive Officer
William Kozy
Director and Chairman
Brooke Story
Independent Director
Chris Barry
Independent Director
Francesco Bianchi
Independent Director
Peter Wilver
Independent Director
Sharon O'Kane
Independent Director
Stacy Enxing Seng
Independent Director
Susan Podlogar
Independent Director
Todd Schermerhorn
Independent Director
Donald Zurbay
Director

Shareholders

Name
Position
Vladimir Makatsaria
Director and Chief Executive Officer
Alex Shvartsburg
Chief Financial Officer
Michael Hutchinson
Senior Vice President, Chief Legal Officer and Company Secretary
Ahmet Tezel
Chief Innovation Officer
Franco Poletti
President, Cardiopulmonary
Stephanie Bolton
President, Global Epilepsy